EUVIMEDEUVIMED entdecken
Crossref

TECR palmitoylation triggers a necrotic cell death program driving acute liver injury

Xiaoyan Ru, Xinran Li, Zhili Wu, Xinhua Ren, Yu Zong, Yazhong Cui, Yuhua Li, Zhangcheng Ding, Xiaodong Wang, Ze Zhang

Cell · 2026-11

DOI: 10.1016/j.cell.2026.10.011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-11. Verfasst von Xiaoyan Ru und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; National Institute of Biological Sciences, Z…. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission, Cancer Research Institute, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute liver injury caused by drug toxicity or immune activation remains a major clinical challenge with limited mechanistic understanding and few effective therapies. Here, we identify a previously unrecognized form of regulated cell death driven by palmitoylation of the endoplasmic reticulum (ER)-resident enzyme trans-2,3-enoyl-coenzyme A (CoA) reductase (TECR). We show that multi-site palmitoylation of TECR, redundantly catalyzed by the palmitoyl acyltransferases ZDHHC5 and ZDHHC2 and dynamically reversed by the depalmitoylase ABHD10, activates PERK-dependent ER stress signaling to trigger cell death. This cell death pathway is a TECR-dependent, palmitoylation-induced, ER stress-mediated necrotic cell death program (TPNCD). TPNCD contributes to liver injury in mouse models of acetaminophen- and concanavalin A-induced hepatotoxicity and is attenuated by hepatocyte-specific TECR ablation or by pharmacological inhibition of palmitoylation or ER stress signaling. Together, these findings establish TPNCD as a distinct, necrotic cell death pathway underlying acute liver injury and highlight new therapeutic entry points for hepatoprotection.

Schlagwörter

Stichwörter der Autor:innen

ABHD10PERKTECRTPNCDZDHHC2ZDHHC5liver injurypalmitoyl acyltransferasepalmitoylation

Autor:innen und Institutionen

  • Graduate School of Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China; National Institute of Biological Sciences, Zhongguancun Life Science Park, Beijing 102206, China.
  • National Institute of Biological Sciences, Zhongguancun Life Science Park, Beijing 102206, China; Peking University, Tsinghua University, National Institute of Biological Sciences (PTN) Joint Graduate Program, School of…
  • National Institute of Biological Sciences, Zhongguancun Life Science Park, Beijing 102206, China; Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 100084, China.
  • Center of Liver Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • National Institute of Biological Sciences, Zhongguancun Life Science Park, Beijing 102206, China.

Förderung

  • Beijing Municipal Science and Technology Commission
  • Cancer Research Institute
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Ru, X., Li, X., Wu, Z., Ren, X., Zong, Y., Cui, Y., Li, Y., Ding, Z., Wang, X., & Zhang, Z. (2026). TECR palmitoylation triggers a necrotic cell death program driving acute liver injury. Cell. https://doi.org/10.1016/j.cell.2026.10.011

Vancouver

Ru X, Li X, Wu Z, Ren X, Zong Y, Cui Y, et al. TECR palmitoylation triggers a necrotic cell death program driving acute liver injury. Cell. 2026. doi:10.1016/j.cell.2026.10.011

BibTeX
@article{Ru2026,
  author = {Ru, Xiaoyan and Li, Xinran and Wu, Zhili and Ren, Xinhua and Zong, Yu and Cui, Yazhong and Li, Yuhua and Ding, Zhangcheng and Wang, Xiaodong and Zhang, Ze},
  title = {TECR palmitoylation triggers a necrotic cell death program driving acute liver injury},
  journal = {Cell},
  year = {2026},
  doi = {10.1016/j.cell.2026.10.011}
}
Kostenlos starten →